Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 2/20 | 0.63 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.63 |
| ▸ | MMP2 | P08253 | 2/20 | 0.63 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.63 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.63 |
| ▸ | RAD52 | P43351 | 1/20 | 0.63 |
| ▸ | GPR84 | Q9NQS5 | 8/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.55 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | FDPS | P14324 | 3/20 | 0.45 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5440695 | 1.00 | PSMD14 (0.63) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL31426886 | 0.98 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL31472851 | 0.98 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Fluoride Ion SCHEMBL2398788 | 0.98 | PSMD14 (0.61) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL28423912 | 0.98 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL9626985 | 0.98 | PSMD14 (0.67) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Phosphoric Acid SCHEMBL23151879 | 0.92 | PSMD14 (0.56) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| SCHEMBL3862567 | 0.90 | PSMD14 (0.52) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL11227182 | 0.88 | PSMD14 (0.72) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Hydrochloric Acid SCHEMBL2912562 | 0.88 | PSMD14 (0.72) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070154546-A1 | Sustained release pharmaceutical compositions | INTERNATIONAL MEDICATION SYSTEMS, LIMITED | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070154546-A1 | Sustained release pharmaceutical compositions | PLA2G2C, PLTP, F12 | PSMD14 3102/4885PLA2G1B 201/4885MMP2 1709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.